Smith & Nephew PLC
SNN32.845USD
+0.145+0.44%
Cierre 12/19, 16:00（ET）Cotizaciones retrasadas 15 min
14.39BCap. mercado
29.22P/E TTM
Más Datos de Smith & Nephew PLC Compañía
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Información de Smith & Nephew PLC
Símbolo de cotizaciónSNN
Nombre de la empresaSmith & Nephew PLC
Fecha de salida a bolsaSep 18, 2087
Director ejecutivoNath (Deepak S)
Número de empleados17349
Tipo de seguridadDepository Receipt
Fin del año fiscalSep 18
DirecciónBuilding 5
CiudadWATFORD
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited Kingdom
Código postalWD18 8YE
Teléfono4401923477100
Sitio Webhttps://www.smith-nephew.com/
Símbolo de cotizaciónSNN
Fecha de salida a bolsaSep 18, 2087
Director ejecutivoNath (Deepak S)
Ejecutivos de Smith & Nephew PLC
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.07%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.35K
+1.08%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+28.58%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.27K
+0.95%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.14K
+2.62%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.07%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
Otro
1.90B
32.62%
Por regiónUSD
Nombre
Ganancia
Proporción
United States of America
3.12B
53.75%
Other Established Markets
1.27B
21.88%
Emerging &internatiuonal market
980.00M
16.87%
United Kingdom
226.00M
3.89%
China
210.00M
3.61%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
Otro
1.90B
32.62%
Estadísticas de accionistas
Actualizado: mar., 18 de nov
Actualizado: mar., 18 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
Otro
97.55%
Accionistas
Accionistas
Proporción
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
Otro
97.55%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
3.66%
Research Firm
2.01%
Investment Advisor/Hedge Fund
1.51%
Hedge Fund
0.27%
Family Office
0.17%
Family Office
0.17%
Pension Fund
0.15%
Family Office
0.12%
Individual Investor
0.01%
Otro
91.94%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
458
32.77M
7.72%
-12.10M
2025Q2
468
34.86M
7.96%
-12.17M
2025Q1
470
32.31M
7.38%
-15.13M
2024Q4
454
34.98M
8.00%
-9.87M
2024Q3
442
33.73M
7.72%
-17.08M
2024Q2
451
37.69M
8.62%
-9.14M
2024Q1
460
34.95M
7.99%
-8.57M
2023Q4
456
32.65M
7.47%
-10.09M
2023Q3
451
40.30M
9.23%
-2.29M
2023Q2
453
39.60M
9.07%
-7.09M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BMO Capital Markets (US)
3.20M
0.75%
+2.62M
+455.42%
Jun 30, 2025
River Road Asset Management, LLC
3.18M
0.75%
+270.48K
+9.30%
Jun 30, 2025
Scharf Investments, LLC
2.08M
0.49%
+6.99K
+0.34%
Jun 30, 2025
Brandes Investment Partners, L.P.
1.60M
0.38%
+63.78K
+4.14%
Jun 30, 2025
Optiver Holding B.V.
1.15M
0.27%
+1.01M
+714.32%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
1.08M
0.25%
-18.79K
-1.72%
Jun 30, 2025
Parametric Portfolio Associates LLC
971.46K
0.23%
-1.36K
-0.14%
Jun 30, 2025
BNP Paribas Securities Corp. North America
644.52K
0.15%
+505.93K
+365.06%
Jun 30, 2025
Morgan Stanley & Co. LLC
823.55K
0.19%
+676.68K
+460.75%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Brandes International ETF
1.07%
ALPS Disruptive Technologies ETF
0.93%
ActivePassive International Equity ETF
0.2%
Avantis Responsible International Equity ETF
0.12%
SP Funds S&P World (ex-US) ETF
0.11%
Avantis International Equity ETF
0.07%
DFA Dimensional International Core Equity 2 ETF
0.04%
State Street SPDR S&P Kensho New Econ Comp ETF
0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
SGI Enhanced Global Income ETF
0%
Brandes International ETF
Proporción1.07%
ALPS Disruptive Technologies ETF
Proporción0.93%
ActivePassive International Equity ETF
Proporción0.2%
Avantis Responsible International Equity ETF
Proporción0.12%
SP Funds S&P World (ex-US) ETF
Proporción0.11%
Avantis International Equity ETF
Proporción0.07%
DFA Dimensional International Core Equity 2 ETF
Proporción0.04%
State Street SPDR S&P Kensho New Econ Comp ETF
Proporción0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
Proporción0.01%
SGI Enhanced Global Income ETF
Proporción0%
Dividendos
Un total de
1.64B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Aug 05, 2025
SNN.NB Final Cash Dividend of gross USD 0.3 paid on Nov 07, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Nov 07, 2025
Oct 03, 2025
Feb 26, 2025
SNN.NB Approximate interim Cash Dividend of gross USD 0.462 paid on May 28, 2025 going ex on Mar 28, 2025
Mar 28, 2025
May 28, 2025
Mar 28, 2025
Sep 24, 2024
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 08, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Nov 08, 2024
Oct 04, 2024
Mar 04, 2024
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 22, 2024 going ex on Apr 01, 2024
Apr 02, 2024
May 22, 2024
Apr 01, 2024
Aug 03, 2023
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 01, 2023 going ex on Oct 05, 2023
Oct 06, 2023
Nov 01, 2023
Oct 05, 2023
Feb 27, 2023
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 17, 2023 going ex on Mar 30, 2023
Mar 31, 2023
May 17, 2023
Mar 30, 2023
Jul 29, 2022
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 26, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 26, 2022
Sep 29, 2022
Mar 14, 2022
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 11, 2022 going ex on Mar 31, 2022
Apr 01, 2022
May 11, 2022
Mar 31, 2022
Aug 12, 2021
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 27, 2021 going ex on Sep 30, 2021
Oct 01, 2021
Oct 27, 2021
Sep 30, 2021
Feb 19, 2021
SNN.NB Final Cash Dividend of gross USD 0.462 paid on May 12, 2021 going ex on Apr 05, 2021
Apr 06, 2021
May 12, 2021
Apr 05, 2021
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Smith & Nephew PLC?
Los cinco principales accionistas de Smith & Nephew PLC son:
BMO Capital Markets (US) posee 3.20M acciones, lo que representa el 0.75% del total de acciones.
River Road Asset Management, LLC posee 3.18M acciones, lo que representa el 0.75% del total de acciones.
Scharf Investments, LLC posee 2.08M acciones, lo que representa el 0.49% del total de acciones.
Brandes Investment Partners, L.P. posee 1.60M acciones, lo que representa el 0.38% del total de acciones.
Optiver Holding B.V. posee 1.15M acciones, lo que representa el 0.27% del total de acciones.
BMO Capital Markets (US) posee 3.20M acciones, lo que representa el 0.75% del total de acciones.
River Road Asset Management, LLC posee 3.18M acciones, lo que representa el 0.75% del total de acciones.
Scharf Investments, LLC posee 2.08M acciones, lo que representa el 0.49% del total de acciones.
Brandes Investment Partners, L.P. posee 1.60M acciones, lo que representa el 0.38% del total de acciones.
Optiver Holding B.V. posee 1.15M acciones, lo que representa el 0.27% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Smith & Nephew PLC?
Los tres principales tipos de accionista de Smith & Nephew PLC son:
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC
¿Cuántas instituciones poseen acciones de Smith & Nephew PLC (SNN)?
A fecha de 2025Q3, 458 instituciones poseen acciones de Smith & Nephew PLC, con un valor de mercado combinado de aproximadamente 32.77M, lo que representa el 7.72% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -0.24%.
¿Cuál es la mayor fuente de ganancias de Smith & Nephew PLC?
El FY2024, el segmento empresarial Sports Medicine Joint Repair generó la ganancia más alta para Smith & Nephew PLC, ascendiendo a 982.00M y representando el 16.90% de la ganancia total.
